CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
Gabapentindrug
Likely dose
Gabapentin 600mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01680549
NCT01680549Phase 4Completed
CompareCT.gov

Pain Control With Total Knee Replacement: Does Gabapentin Affect Narcotic Usage and Functional Outcome? A Randomized Controlled Trial.

Texas Tech University Health Sciences Center·interventional·Posted Sep 7, 2012·Updated Jan 31, 2024

In Brief

A Phase 4 clinical trial evaluating Gabapentin for Postoperative Pain. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this project is to study the effects of gabapentin on pain control in the perioperative and post-operative period of total knee arthroplasty.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2012
Enrollment StartSep 1, 2012
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 13.8 years ago

Interventions

Gabapentindrug

Gabapentin 600mg PO pre-operatively and continued postoperatively 300 mg PO q8 hours x 3 days.